TY - JOUR AU - Mashima, R. AU - Hishida, Y. AU - Tezuka, T. AU - Yamanashi, Y. PY - 2009 DA - 2009// TI - The roles of Dok family adapters in immunoreceptor signaling JO - Immunol Rev VL - 232 UR - https://doi.org/10.1111/j.1600-065X.2009.00844.x DO - 10.1111/j.1600-065X.2009.00844.x ID - Mashima2009 ER - TY - JOUR AU - Favre, C. AU - Gérard, A. AU - Clauzier, E. AU - Pontarotti, P. AU - Olive, D. AU - Nunès, J. A. PY - 2003 DA - 2003// TI - DOK4 and DOK5: new Dok-related genes expressed in human T cells JO - Genes Immun VL - 4 UR - https://doi.org/10.1038/sj.gene.6363891 DO - 10.1038/sj.gene.6363891 ID - Favre2003 ER - TY - JOUR AU - Berger, A. H. AU - Niki, M. AU - Morotti, A. PY - 2010 DA - 2010// TI - Identification of DOK genes as lung tumor suppressors JO - Nat Genet VL - 42 UR - https://doi.org/10.1038/ng.527 DO - 10.1038/ng.527 ID - Berger2010 ER - TY - JOUR AU - Mashima, R. AU - Honda, K. AU - Yang, Y. PY - 2010 DA - 2010// TI - Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma JO - Lab Invest VL - 90 UR - https://doi.org/10.1038/labinvest.2010.121 DO - 10.1038/labinvest.2010.121 ID - Mashima2010 ER - TY - JOUR AU - Stork, B. AU - Neumann, K. AU - Goldbeck, I. PY - 2007 DA - 2007// TI - Subcellular localization of Grb2 by the adaptor protein Dok-3 restricts the intensity of Ca2+ signaling in B cells JO - EMBO J VL - 26 UR - https://doi.org/10.1038/sj.emboj.7601557 DO - 10.1038/sj.emboj.7601557 ID - Stork2007 ER - TY - JOUR AU - Robson, J. D. AU - Davidson, D. AU - Veillette, A. PY - 2004 DA - 2004// TI - Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3 JO - Mol Cell Biol VL - 24 UR - https://doi.org/10.1128/MCB.24.6.2332-2343.2004 DO - 10.1128/MCB.24.6.2332-2343.2004 ID - Robson2004 ER - TY - JOUR AU - Peng, Q. AU - O’Loughlin, J. L. AU - Humphrey, M. B. PY - 2012 DA - 2012// TI - DOK3 negatively regulates LPS responses and endotoxin tolerance JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0039967 DO - 10.1371/journal.pone.0039967 ID - Peng2012 ER - TY - JOUR AU - Kim, S. S. AU - Lee, K. G. AU - Chin, C. S. PY - 2014 DA - 2014// TI - DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation JO - J Immunol VL - 193 UR - https://doi.org/10.4049/jimmunol.1301601 DO - 10.4049/jimmunol.1301601 ID - Kim2014 ER - TY - JOUR AU - Sabatos, C. A. AU - Chakravarti, S. AU - Cha, E. PY - 2003 DA - 2003// TI - Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance JO - Nat Immunol VL - 4 UR - https://doi.org/10.1038/ni988 DO - 10.1038/ni988 ID - Sabatos2003 ER - TY - JOUR AU - Sánchez-Fueyo, A. AU - Tian, J. AU - Picarella, D. PY - 2003 DA - 2003// TI - Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance JO - Nat Immunol VL - 4 UR - https://doi.org/10.1038/ni987 DO - 10.1038/ni987 ID - Sánchez-Fueyo2003 ER - TY - JOUR AU - Liberal, R. AU - Grant, C. R. AU - Holder, B. S. PY - 2012 DA - 2012// TI - The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway JO - Hepatology VL - 56 UR - https://doi.org/10.1002/hep.25682 DO - 10.1002/hep.25682 ID - Liberal2012 ER - TY - JOUR AU - Wu, W. AU - Shi, Y. AU - Li, S. PY - 2012 DA - 2012// TI - Blockade of Tim-3 signaling restores the virus-specific CD8+ T-cell response in patients with chronic hepatitis B JO - Eur J Immunol VL - 42 UR - https://doi.org/10.1002/eji.201141852 DO - 10.1002/eji.201141852 ID - Wu2012 ER - TY - JOUR AU - Monney, L. AU - Sabatos, C. A. AU - Gaglia, J. L. PY - 2002 DA - 2002// TI - Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease JO - Nature VL - 415 UR - https://doi.org/10.1038/415536a DO - 10.1038/415536a ID - Monney2002 ER - TY - JOUR AU - Zhang, Y. AU - Ma, C. J. AU - Wang, J. M. PY - 2011 DA - 2011// TI - Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection JO - PLoS ONE VL - 6 UR - https://doi.org/10.1371/journal.pone.0019664 DO - 10.1371/journal.pone.0019664 ID - Zhang2011 ER - TY - JOUR AU - Chiba, S. AU - Baghdadi, M. AU - Akiba, H. PY - 2012 DA - 2012// TI - Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 JO - Nat Immunol VL - 13 UR - https://doi.org/10.1038/ni.2376 DO - 10.1038/ni.2376 ID - Chiba2012 ER - TY - JOUR AU - Ndhlovu, L. C. AU - Lopez-Vergès, S. AU - Barbour, J. D. PY - 2012 DA - 2012// TI - Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-11-392951 DO - 10.1182/blood-2011-11-392951 ID - Ndhlovu2012 ER - TY - JOUR AU - Anderson, A. C. PY - 2012 DA - 2012// TI - Tim-3, a negative regulator of anti-tumor immunity JO - Curr Opin Immunol VL - 24 UR - https://doi.org/10.1016/j.coi.2011.12.005 DO - 10.1016/j.coi.2011.12.005 ID - Anderson2012 ER - TY - JOUR AU - Kang, C. W. AU - Dutta, A. AU - Chang, L. Y. PY - 2015 DA - 2015// TI - Apoptosis of tumor infiltrating effector TIM-3+ CD8+ T cells in colon cancer JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep15659 DO - 10.1038/srep15659 ID - Kang2015 ER -